Rythmodan
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
SummaryEight healthy male volunteers took a single oral dose of one of the following: Rythmodan (conventionally formulated…
SummaryThe bioavailability of two slow release preparations of disopyramide has been compared in a randomized cross-over trial of…
A Phase I Study was carried out on disopyramide phosphate retard (slow-release) tablets in healthy Japanese subjects, employing…
The authors had 75 patients with myocardial infarction under observation. After the 15th day of the disease various disorders of…
Some pharmacokinetic parameters of disopyramide in a steady-state situation were studied in 8 patients with arrhythmias. Four…
Disopyramide (Rythmodan - Roussel) is an anti-arrhythmic drug for oral use which is being promoted as a ‘new cardio-specific for…